Skip to main content

Table 2 Isolated bacteria by intervention group

From: Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units

  No oral switch (n = 238) Oral switch (n = 111) All (n = 349) P-value
N % N % N %
Negative 129 54% 76 69% 205 59% 0.024
Gram-negative 72 30% 17 15%    0.027
Enterobacter spp. 23 10% 4 4% 16 5% 0.139
  Multisusceptible 7   4   11   
  ESBL-producing 16   0   16   
Escherichia coli 14 6% 4 4% 18 5% 0.531
  Multisusceptible 14   4   18   
Klebsiella spp. 12 5% 3 3% 15 4% 0.468
  Multisusceptible 4   3   7   
  Carbapenemase-producing 8   0   8   
Pseudomonas aeruginosa 11 5% 2 2% 13 4% 0.332
  Multisusceptible 11   2   13   
Serratia spp. 6 3% 1 1% 7 2% 0.449
  Multisusceptible 6   1   7   
Acinetobacter baumannii 0 0% 1 1% 1 0%
Proteus spp. 1 0% 1 1% 2 1% 0.433
  Multisusceptible 1 0% 1 1% 2   
Burkholderia cepacia 2 1% 0 0% 2 1%
Aeromonas hydrophila 1 0% 1 1% 2 1% 0.433
Citrobacter spp. 1 0% 0 0% 1 0%
Haemophilus spp. 1 0% 0 0% 1 0% 0.433
Gram-positive 26 11% 15 14%    0.027
Stenotrophomonas maltophilia 1 0% 1 1% 2 1% 0.433
Listeria monocytogenes 1 0% 0 0% 1 0%
CN Staphylococcus 0 0% 1 1% 1 0% 0.433
Staphylococcus aureus 14 6% 6 5% 20 6% 0.372
  MSSA 5 2% 3 3% 8 2%  
  MRSA 9 4% 3 3% 12 3%  
Streptococcus pneumoniae 4 2% 4 4% 8 2% 0.097
Enterococcus spp. 4 2% 1 1% 4 1% 0.403
Streptococcus spp. 1 0% 1 1% 2 1% 0.433
Others
Pneumocystis jirovecii 0 0% 1 1% 1 0%
Candida albicans 1 0% 0 0% 1 0%
 Polymicrobial 2 1% 0 0% 2 1%
Total 238 100% 110 100% 348   
  1. ESBL Extended-spectrum beta-lactamases, MSSA Methicillin-susceptible Staphylococcus aureus, MRSA Methicillin-resistant Staphylococcus aureus, CN Coagulase negative